All for Testing—But Maybe Not Glycemic Testing for All
As the population’s diabetes risk increases, the medical community looks at expanding glycemic testing for inpatients
Read MorePosted by Clinical Lab Products | Oct 2, 2012 | Miscellaneous |
As the population’s diabetes risk increases, the medical community looks at expanding glycemic testing for inpatients
Read MorePosted by Clinical Lab Products | Sep 27, 2012 | Miscellaneous |
Pathway Genomics Corp, San Diego, has partnered with La Jolla, Calif, medical practice MD Revolution.
Read MorePosted by Clinical Lab Products | Sep 12, 2012 | Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Jay M. Lieberman, MD, an expert in infectious diseases and emerging infectious diseases, is medical director of infectious diseases for Quest Diagnostics, Madison, NJ, and medical and laboratory director for Focus Diagnostics. CLP spoke with him about the West Nile virus outbreak.
Read MorePosted by Clinical Lab Products | Aug 15, 2012 | Diabetes & Metabolic Diseases |
The strategy consists of a risk assessment, followed, where necessary, by a blood test to confirm whether people have the disease, or are at high risk of developing it.
Read MorePosted by Clinical Lab Products | Aug 7, 2012 | Controls, Quality Systems |
Blood-Based Control Product stablity provides increased flexibility The Dropper® A1c Diabetes Control from Quantimetrix, Redondo Beach, Calif, is a liquid, human blood-based control for laboratory and point-of-care (POCT) hemoglobin A
Read More